Thailand
· Delayed Price · Currency is THB Inter Pharma PCL Statistics
Total Valuation
Inter Pharma PCL has a market cap or net worth of THB 2.68 billion. The enterprise value is 2.90 billion.
| Market Cap | 2.68B |
| Enterprise Value | 2.90B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | May 7, 2024 |
Share Statistics
Inter Pharma PCL has 605.34 million shares outstanding. The number of shares has increased by 2.16% in one year.
| Shares Outstanding | 605.34M |
| Shares Change (YoY) | +2.16% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 34.76% |
| Owned by Institutions (%) | 1.15% |
| Float | 273.87M |
Valuation Ratios
The trailing PE ratio is 131.20.
| PE Ratio | 131.20 |
| Forward PE | n/a |
| PS Ratio | 1.48 |
| PB Ratio | 1.39 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.32, with an EV/FCF ratio of 140.79.
| EV / Earnings | 142.19 |
| EV / Sales | 1.60 |
| EV / EBITDA | 21.32 |
| EV / EBIT | 52.09 |
| EV / FCF | 140.79 |
Financial Position
The company has a current ratio of 2.49, with a Debt / Equity ratio of 0.16.
| Current Ratio | 2.49 |
| Quick Ratio | 1.65 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 2.41 |
| Debt / FCF | 16.21 |
| Interest Coverage | 2.58 |
Financial Efficiency
Return on equity (ROE) is 1.02% and return on invested capital (ROIC) is 1.45%.
| Return on Equity (ROE) | 1.02% |
| Return on Assets (ROA) | 1.24% |
| Return on Capital (ROIC) | 1.45% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.62 |
| Inventory Turnover | 3.08 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.08% in the last 52 weeks. The beta is 0.57, so Inter Pharma PCL's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | -28.08% |
| 50-Day Moving Average | 4.21 |
| 200-Day Moving Average | 5.05 |
| Relative Strength Index (RSI) | 43.14 |
| Average Volume (20 Days) | 695,565 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Inter Pharma PCL had revenue of THB 1.81 billion and earned 20.39 million in profits. Earnings per share was 0.03.
| Revenue | 1.81B |
| Gross Profit | 665.39M |
| Operating Income | 57.98M |
| Pretax Income | 33.16M |
| Net Income | 20.39M |
| EBITDA | 95.94M |
| EBIT | 57.98M |
| Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has 310.92 million in cash and 333.92 million in debt, giving a net cash position of -22.99 million or -0.04 per share.
| Cash & Cash Equivalents | 310.92M |
| Total Debt | 333.92M |
| Net Cash | -22.99M |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | 2.12B |
| Book Value Per Share | 3.17 |
| Working Capital | 640.38M |
Cash Flow
In the last 12 months, operating cash flow was 153.16 million and capital expenditures -132.56 million, giving a free cash flow of 20.60 million.
| Operating Cash Flow | 153.16M |
| Capital Expenditures | -132.56M |
| Free Cash Flow | 20.60M |
| FCF Per Share | 0.03 |
Margins
Gross margin is 36.78%, with operating and profit margins of 3.20% and 1.13%.
| Gross Margin | 36.78% |
| Operating Margin | 3.20% |
| Pretax Margin | 1.83% |
| Profit Margin | 1.13% |
| EBITDA Margin | 5.30% |
| EBIT Margin | 3.20% |
| FCF Margin | 1.14% |
Dividends & Yields
This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 0.49%.
| Dividend Per Share | 0.02 |
| Dividend Yield | 0.49% |
| Dividend Growth (YoY) | -68.58% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 63.67% |
| Buyback Yield | -2.16% |
| Shareholder Yield | -1.66% |
| Earnings Yield | 0.76% |
| FCF Yield | 0.77% |
Stock Splits
The last stock split was on May 7, 2024. It was a forward split with a ratio of 1.625.
| Last Split Date | May 7, 2024 |
| Split Type | Forward |
| Split Ratio | 1.625 |
Scores
Inter Pharma PCL has an Altman Z-Score of 3.82.
| Altman Z-Score | 3.82 |
| Piotroski F-Score | n/a |